Intellia Therapeutics Stock Forecast - Rate Of Daily Change
| NTLA Stock | USD 14.30 0.50 3.62% |
Intellia Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Intellia Therapeutics stock prices and determine the direction of Intellia Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Intellia Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Intellia |
| Previous Rate Of Daily Change | Rate Of Daily Change | Trend |
| 1.02 | 1.04 |
| Check Intellia Therapeutics Volatility | Backtest Intellia Therapeutics | Information Ratio |
Intellia Therapeutics Trading Date Momentum
| On November 25 2024 Intellia Therapeutics was traded for 14.30 at the closing time. The top price for the day was 14.58 and the lowest listed price was 13.64 . There was no trading activity during the period 0.0. Lack of trading volume on November 25, 2024 did not cause price change. The trading delta at closing time against the current closing price is 2.10% . |
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
| Compare Intellia Therapeutics to competition |
Other Forecasting Options for Intellia Therapeutics
For every potential investor in Intellia, whether a beginner or expert, Intellia Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Intellia Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Intellia. Basic forecasting techniques help filter out the noise by identifying Intellia Therapeutics' price trends.Intellia Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intellia Therapeutics stock to make a market-neutral strategy. Peer analysis of Intellia Therapeutics could also be used in its relative valuation, which is a method of valuing Intellia Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Intellia Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Intellia Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Intellia Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Intellia Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Intellia Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intellia Therapeutics shares will generate the highest return on investment. By undertsting and applying Intellia Therapeutics stock market strength indicators, traders can identify Intellia Therapeutics entry and exit signals to maximize returns.
Intellia Therapeutics Risk Indicators
The analysis of Intellia Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Intellia Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting intellia stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.18 | |||
| Standard Deviation | 4.33 | |||
| Variance | 18.75 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Intellia Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intellia Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intellia Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intellia Therapeutics Stock:Check out Historical Fundamental Analysis of Intellia Therapeutics to cross-verify your projections. For information on how to trade Intellia Stock refer to our How to Trade Intellia Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intellia Therapeutics. If investors know Intellia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intellia Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.45) | Revenue Per Share 0.449 | Quarterly Revenue Growth (0.24) | Return On Assets (0.28) | Return On Equity (0.52) |
The market value of Intellia Therapeutics is measured differently than its book value, which is the value of Intellia that is recorded on the company's balance sheet. Investors also form their own opinion of Intellia Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Intellia Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intellia Therapeutics' market value can be influenced by many factors that don't directly affect Intellia Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intellia Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Intellia Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intellia Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.